Richard Bloomfield > Goodwin > London, England > Lawyer Profile

Goodwin‘s M&A practice has a strong corporate offering and cross-border capabilities which continues to attract new clients, particularly from the life sciences and technology sectors. The team is jointly led by life sciences expert Graham Defries; technology and life sciences authorities David Mardle and Andrew Davis; and real estate specialist James Spence. Defries has extensive experience advising biotech and pharmaceutical companies on private equity and venture capital investments and exits, as well as M&A, corporate financing, and licensing deals – both domestic and cross-border in nature. Davis is praised for his ‘business acumen, attention to detail, and common sense‘, while Spence’s real estate-focused practice encompasses investments in Europe, structured sales and acquisitions, and real estate funds work. Andrew Harrow concentrates on UK and international transactions including joint ventures, M&A, reorganisations, IPOs, and fundraising. Other key names in the team include Adam Thatcher, Lucy Thomas, and Richard Bloomfield.

Representing a host of start-ups, emerging growth companies, and late-stage mature corporates, the Goodwin team leverages its ‘strong market knowledge’ to advise on high-value fundraisings and seed rounds. The practice boasts in-depth expertise across healthcare, AI, and environmental matters, often working closely with the firm’s private equity division to support clients in growth equity transactions and complex exits. The team is chaired by David Mardle, an expert in capital markets transactions. Sophie McGrath utilises her ‘vast dealmaking experience’ in private and public financings. Both Andrew Davis and Andrew Harrow primarily focus on joint ventures and growth capital financings. Based in Cambridge, Elizabeth Rhodes and Adam Thatcher are noted for their M&A expertise. Other key figures include Kenny Walker-Durrant, who regularly acts for venture capital investors, as well as Richard Bloomfield and Ella Donegan. Ali Ramadan left to join Cooley (UK) LLP in September 2024.